Back to News
Market Impact: 0.55

Allegiant Travel (ALGT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

ALGT
Corporate EarningsCompany FundamentalsAnalyst EstimatesTravel & LeisureMarket Technicals & FlowsAnalyst Insights
Allegiant Travel (ALGT) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Allegiant Travel (ALGT) reported mixed Q2 2025 results, with revenue of $689.38 million missing consensus by 1.29%, yet significantly beating EPS estimates at $1.23, driven by better-than-anticipated cost control as operating CASM came in below forecasts. While capacity (ASMs) and load factor exceeded expectations, total revenue per ASM (TRASM) slightly missed. The stock has underperformed, down 20.2% over the past month, and holds a Zacks Rank #4 (Sell), indicating investor skepticism despite operational efficiencies.

Analysis

Allegiant Travel's Q2 2025 results present a conflicting picture, defined by a significant bottom-line beat overshadowed by top-line weakness and negative market sentiment. The company reported EPS of $1.23, decisively beating the $0.83 consensus estimate by 48.19%, a performance driven by superior cost management. Key cost metrics were favorable, with airline operating CASM ex-fuel at 7.68 cents, well below the 8.32 cents estimated by analysts. However, this operational efficiency was contrasted by a revenue miss of 1.29%, with total revenue coming in at $689.38 million. This weakness was reflected in key pricing metrics, as scheduled service TRASM of 11.57 cents fell short of the 11.77 cents consensus. While operational metrics like load factor (81.2% vs 80.6% estimate) and available seat miles were slightly ahead of forecasts, the year-over-year EPS declined from $1.77. The stock's -20.2% return over the past month, coupled with a Zacks Rank #4 (Sell), indicates investors are weighing the revenue miss and year-over-year profit decline more heavily than the impressive cost control.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo